{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:51:26Z","timestamp":1790952686898,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Zhejiang Medical and Health Science and Technology Project","award":["2020381348"],"award-info":[{"award-number":["2020381348"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.molimm.2020.01.008","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T05:12:20Z","timestamp":1580101940000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis"],"prefix":"10.1016","volume":"119","author":[{"given":"Hao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2020.01.008_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1479-5876-9-146","article-title":"An immunologic portrait of cancer","volume":"9","author":"Ascierto","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2020.01.008_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2020.01.008_bib0015","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41467-018-05047-1","article-title":"Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma","volume":"9","author":"Brochez","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2020.01.008_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/gcc.22365","article-title":"Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) \u2013 associations with gene expression, mutational load, and survival","volume":"55","author":"Budczies","year":"2016","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molimm.2020.01.008_bib0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/bonekey.2014.95","article-title":"Immune regulation of bone metastasis","volume":"3","author":"Capietto","year":"2014","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.molimm.2020.01.008_bib0030","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-02-0474","article-title":"T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG\/TRAIL interaction","volume":"104","author":"Colucci","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.molimm.2020.01.008_bib0035","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1634\/theoncologist.2011-0427","article-title":"Systematic review and network meta-analysis of overall survival comparing 3 mg\/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma","volume":"17","author":"Dequen","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.molimm.2020.01.008_bib0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2020.01.008_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2012-202253","article-title":"Cytokine-producing B cells as regulators of pathogenic and protective immune responses","volume":"72","author":"Fillatreau","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2020.01.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001145","article-title":"Clarifying the mechanism of superantigen toxicity","volume":"9","author":"Fraser","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molimm.2020.01.008_bib0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.humpath.2016.03.022","article-title":"Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome","volume":"54","author":"Garg","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0065","doi-asserted-by":"crossref","first-page":"35651","DOI":"10.1038\/srep35651","article-title":"PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer","volume":"6","author":"Guan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2020.01.008_bib0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.molmed.2018.03.006","article-title":"Macrophages: the road less traveled, changing anticancer therapy","volume":"24","author":"Guerriero","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molimm.2020.01.008_bib0075","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1172\/JCI59266","article-title":"Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice","volume":"121","author":"Horikawa","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.01.008_bib0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jcp.2005.028860","article-title":"Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions","volume":"59","author":"Hussein","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41467-017-00608-2","article-title":"Predictors of responses to immune checkpoint blockade in advanced melanoma","volume":"8","author":"Jacquelot","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2020.01.008_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2011.04.032","article-title":"Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006","volume":"65","author":"Jemal","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0095","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2020.01.008_bib0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00262-011-1071-x","article-title":"Prognostic impact of B-cell density in cutaneous melanoma","volume":"60","author":"Lad\u00e1nyi","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.molimm.2020.01.008_bib0105","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/eji.201344062","article-title":"TGF-\u03b2-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance","volume":"44","author":"Lee","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0110","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/his.12437","article-title":"A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma","volume":"65","author":"Martinez-Rodriguez","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.molimm.2020.01.008_bib0115","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.01.008_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068171","article-title":"T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer","volume":"8","author":"Monteiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.01.008_bib0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2020.01.008_bib0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2006.02.005","article-title":"B cells as antigen presenting cells","volume":"238","author":"Rodr\u00edguez-Pinto","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0140","first-page":"29","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molimm.2020.01.008_bib0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cncr.30946","article-title":"Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies","volume":"124","author":"Sloot","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.molimm.2020.01.008_bib0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molimm.2020.01.008_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI10763","article-title":"Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection","volume":"106","author":"Teng","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2020.01.008_bib0160","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4161\/21645515.2014.983409","article-title":"PD-1 and PD-l1 antibodies for melanoma","volume":"10","author":"Tsai","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.molimm.2020.01.008_bib0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejca.2017.06.028","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies\u2013update 2017","volume":"83","author":"Ugurel","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molimm.2020.01.008_bib0170","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00268-010-0448-x","article-title":"Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma","volume":"34","author":"Wang","year":"2010","journal-title":"World J. Surg."},{"key":"10.1016\/j.molimm.2020.01.008_bib0175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2020.01.008_bib0180","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fphar.2018.00536","article-title":"Regulation of PD-L1: emerging routes for targeting tumor immune evasion","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0185","article-title":"MTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2020.01.008_bib0190","doi-asserted-by":"crossref","first-page":"E999","DOI":"10.3390\/ijms20040999","article-title":"The contribution of the immune system in bone metastasis pathogenesis","volume":"20","author":"Xiang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2020.01.008_bib0195","article-title":"B cells promote tumor progression via STAT3 regulated-angiogenesis","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.01.008_bib0200","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3389\/fimmu.2018.02241","article-title":"PD-L1+ Regulatory B cells are significantly decreased in rheumatoid arthritis patients and increase after successful treatment","volume":"9","author":"Zacca","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/17469872.3.5.569","article-title":"Current concepts of metastasis in melanoma","volume":"3","author":"Zbytek","year":"2008","journal-title":"Expert Rev. Dermatol."},{"key":"10.1016\/j.molimm.2020.01.008_bib0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/intimm\/dxv034","article-title":"Regulatory B cells in anti-tumor immunity","volume":"27","author":"Zhang","year":"2015","journal-title":"Int. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019305723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019305723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:33:37Z","timestamp":1758980017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019305723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"alternative-id":["S0161589019305723"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.01.008","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}